100
Participants
Start Date
May 31, 2022
Primary Completion Date
September 23, 2024
Study Completion Date
December 31, 2029
Tadalafil 20 MG
Daily dose of oral over-encapsulated tadalafil tablets (20 mg) for three months.
Placebo
Daily dose of oral over-encapsulated placebo tablets for three months.
Danish Research Centre for Magnetic Resonance, Hvidovre
Department of Neurology, Herlev Gentofte Hospital, Herlev
Danish Research Centre for Magnetic Resonance
OTHER
Bispebjerg Hospital
OTHER
Rigshospitalet, Denmark
OTHER
University of Copenhagen
OTHER
The Novo Nordic Foundation
OTHER
Nordsjaellands Hospital
OTHER
Christina Kruuse
OTHER